Tag: CONVERTIBLEEXCHANGEABLE
NOTICE TO HOLDERS OF BONDS CONVERTIBLE/EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL AMOUNT OF 24,999,975.99 EUROS – 08/02/2023 at 6:00 p.m.
PARIS, France, August 2, 2023 – 6:00 p.m. (CET) – Abivax SA (Euronext Paris: FR0012333284 – ABVX), a clinical-stage Phase 3 biotechnology company developing drugs that modulate the immune system…
NOTICE TO HOLDERS OF BONDS CONVERTIBLE/EXCHANGEABLE FOR NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL AMOUNT OF 24,999,975.99 EUROS – 01/31/2023 at 6:00 p.m.
PARIS, France, January 31, 2023 – 6:00 p.m. (CET) – Abivax SA (Euronext Paris: FR0012333284 – ABVX), Phase 3 clinical-stage biotechnology company developing drugs that modulate the immune system to…